Archive | Health Professionals

New humanized mouse model provides insight into immunotherapy resistance

Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance to immune checkpoint blockade therapies in melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Regression may predict good prognosis in stage 1 and 2 cutaneous melanomas

Disease regression was associated with improved recurrence-free survival and overall survival among certain patients with stage 1 and 2 cutaneous melanomas, according to a study.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma

Philogen S.p.A., a clinical-stage biotechnology company focused on antibody-based therapeutics, is pleased to announce that 50% of the expected events for the primary outcome analysis of the PIVOTAL study were reached in December 2020.

Read the full story

Posted in Melanoma News, Health Professionals, Clinical Trials

World first melanoma success in Australia prompts new trial

A Sydney man who was seriously ill with advanced melanoma has made a remarkable recovery after receiving a drug reserved for breast and ovarian cancer.

Read the full story

Posted in Melanoma News, Health Professionals, Patients, Clinical Trials, Latest News